After eight years of follow-up, there was a significant increase in DFS in stage III patients treated with FLOX and a trend toward improved OS, which did not reach statistical significance.
← all excerpts
SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023).
1
—
—